All News

While studying the genes in poplar trees that control callus formation, scientists at Oak Ridge National Laboratory have uncovered genetic networks at the root of tumor formation in several human cancers.

Scientists at the Department of Energy’s Oak Ridge National Laboratory have created a recipe for a renewable 3D printing feedstock that could spur a profitable new use for an intractable biorefinery byproduct: lignin.

To learn more about interactions between drug molecules and micelles, Associate Professor Megan Robertson and graduate students Tyler Cooksey and Tzu-Han Li from the University of Houston (UH) are using neutrons at the Department of Energy’s (DOE’s) Oak Ridge National Laboratory (ORNL).

A team of scientists, led by University of Guelph professor John Dutcher, are using neutrons at ORNL’s Spallation Neutron Source to unlock the secrets of natural nanoparticles that could be used to improve medicines.

Two leaders in US manufacturing innovation, Thomas Kurfess and Scott Smith, are joining the Department of Energy’s Oak Ridge National Laboratory to support its pioneering research in advanced manufacturing.

The next cohort of Innovation Crossroads fellows at Oak Ridge National Laboratory will receive support from the U.S. Department of Energy’s Advanced Manufacturing Office (AMO) and the Tennessee Valley Authority (TVA). Officials made the announcement today at th...

The construction industry may soon benefit from 3D printed molds to make concrete facades, promising lower cost and production time. Researchers at Oak Ridge National Laboratory are evaluating the performance of 3D printed molds used to precast concrete facades in a 42-story buildin...

Oak Ridge National Laboratory scientists have improved a mixture of materials used to 3D print permanent magnets with increased density, which could yield longer lasting, better performing magnets for electric motors, sensors and vehicle applications. Building on previous research, ...

The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.